Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivermectin in Early COVID-19 (SAINT-PERU)
NCT04635943Phase 2Completed
- Sponsor
- Universidad Peruana Cayetano Heredia
- Start
- Aug 2020
- Primary completion
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of CHILD-IVITAB in coronavirus disease 2019 (COVID-19), sponsored by Universidad Peruana Cayetano Heredia. Started Aug 2020; status: completed.
02
Drugs
CHILD-IVITAB
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04635943.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04635943.